Hays Waldrop Discusses How The Institute of Healthcare Executives and Suppliers Provides Value Through the Exchange of Industry Knowledge and Experience”

Technology is in a constant state of change, especially with new innovations in healthcare happening every day. But it’s not always easy to know what’s out there, or to get your product to market. In today’s connected world, it has become more important than ever to have a community that you can chat with, learn from, and bounce ideas off of. Networking is in.

But how do networking events in healthcare bring value to the industry?

On the latest episode of I Don’t Care with Host Kevin Stevenson, guest Hays Waldrop, Founder and President of the Institute of Healthcare Executives and Suppliers, discusses the foundation of IHES and the importance of networking in the healthcare field.

Waldrop’s ‘Aha!’ moment came when he was working with a start-up in healthcare that had a product catered towards those with learning disabilities. While the doctors and healthcare professionals loved the product, so too, did schools. So when he saw the superintendents and leaders of school districts gathered to network and chat about different products, he had a realization: why wasn’t this happening in healthcare?

So, over the course of 20 years, Waldrop networked to form a conglomerate of healthcare professionals. “We’ve got a CEO group, I’ve got a supply-chain group, and also a pharmacy group, and so we come together and it’s a live-event business and we connect providers and suppliers in this environment.”

The two also discussed…

  • The different events IHES holds and how it creates a positive learning environment
  • What type of sessions and networking events there are and who attends
  • What the criteria are for adding in newer suppliers and start-ups

“You know, if you’re just the same old ‘me too’ commodity, that’s not real attractive necessarily, they’re necessary and yeah we clearly have those…but it’s always cool when you have a new technology, something different that the executives perhaps have not seen before or maybe they’re doing it just differently…,” said Waldrop.

Hays Waldrop has over 25 years of experience in the healthcare industry, having first started working in Territory Sales for Biomet, an orthopedic implant company. After working with a few start-ups around the dot com boom, Waldrop formed IHES, a group of three networking and learning platforms for healthcare executives and suppliers. He is a graduate of the University of Tennessee, Knoxville.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More